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Abstract 
Mathematical models of skin permeability play an important role in various fields including 
prediction of transdermal drug delivery and assessment of dermal exposure to industrial 
chemicals. Extensive research has been performed over the last several decades to yield 
predictions of skin permeability to various molecules. These efforts include the development of 
empirical approaches such as quantitative structure-permeability relationships and porous 
pathway theories as well as the establishment of rigorous structure-based models. In addition to 
establishing the necessary mathematical framework to describe these models, efforts have also 
been dedicated to determining the key parameters that are required to use these models. This 
article provides an overview of various modeling approaches with respect to their advantages, 
limitations and future prospects.   
 
Key words: Transdermal, Stratum corneum, Permeability, Model, Theory. Mathematical, 
Exposure assessment 
 
  
3 
 
Table of Contents 
1. Introduction  
 
2. Steady-state models  
2.1. QSPR  
2.2. Structure-based models  
2.3 Porous pathway model  
 
3. Transient Models  
3.1. Basic models 
3.2. Compartmental models 
3.3. Complex models 
 
4.  Estimation of parameters  
4.1. Partition coefficient 
4.2. Diffusion coefficient  
4.3. Diffusion path length  
 
5. Mathematical approaches 
5.1. Laplace Transforms  
5.2. Finite Differences  
5.3. Finite Elements  
5.4. Random Walk 
5.5. Exposure assessment   
 
6. Summary and Outlook 
4 
 
1. INTRODUCTION  
 
Mathematical models of skin permeability are highly relevant to the fields of transdermal 
drug delivery, assessment of dermal exposure to industrial and environmental hazards as well as 
in developing fundamental understanding of biotransport processes. The impact of such models 
on transdermal drug delivery has been particularly significant. Transdermal delivery provides an 
appealing alternative to other modes of drug administration. Transdermal patches, introduced 
first in the United States in 1979 for scopolamine delivery, are now available for a total of 19 
drugs. Between 2003 and 2007, new transdermal delivery systems were introduced at a 
remarkable pace; one every 7.5 months (Prausnitz & Langer 2008). Expanding the scope of 
transdermal drug delivery to a wide range of drugs, however, has proved to be a significant 
challenge. Skin has evolved to provide a highly effective barrier for the permeation of 
xenobiotics and loss of water (Scheuplein & Blank 1971b). This has made it very challenging to 
deliver drugs across the skin. The outermost layer of skin, the stratum corneum (SC), is primarily 
composed of terminally differentiated keratinocytes (corneocytes) embedded in lipid layers 
(Elias 1983). The unique organization of the SC, in particular its lipid components, offers a 
substantial barrier to drug delivery and absorption of toxic substances (Potts et al 1991).  
 
 While major advances in our understanding of the fundamental mechanisms underlying 
skin permeation have been made in the past 70 years, topical and transdermal drug delivery has 
been practiced since ancient times. The Ebers papyrus, dating to 1550 B.C., offers numerous 
remedies and formulations for the management of skin conditions (Bryan 1930.). There are also 
reports of ―flying ointment‖ in the historical literature where preparations containing 
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hallucinogenic substances were formulated in lipophilic bases (Rudgley 1993.). Such 
preparations were intended to be applied on a broomstick held between the legs, indicating an 
early knowledge of the importance of the formulation, site variation in permeability and the 
ability to achieve systemic effects using preparations applied to the skin.   
 
 The foundations of predictive modeling of transdermal and topical delivery were laid in 
the 1940‘s to 1970‘s. During this time it was recognized that partitioning and solubility were 
important factors that determine skin penetration. In the early 40‘s Rothman identified the 
importance of the physicochemical properties of the permeant such as solubility and the critical 
influence of the vehicle on permeation (Rothman 1943).  In the mid 1950‘s Hadgraft and Somers 
observed that solutes with a balanced partition coefficient, that is, those that possess a log 
[octanol-water partition coefficient, P] between 1 and 3 are associated with optimum skin 
permeation  (Hadgraft & Somers 1956). In the 1950‘s and 1960‘s efforts to understand how the 
skin permeation process could be predicted in a systematic manner were largely driven by the 
chemical defense industry (Treherne 1956; Tregear 1966.). 
 
With the recognition that the transport processes in skin can be described by Fick‘s first 
law, Higuchi derived mathematical models that describe percutaneous absorption as a passive 
diffusion process in the vehicle and the membrane layers in series (Higuchi 1960). Using basic 
physicochemical principles, his seminal contributions also demonstrated the importance of the 
thermodynamic activity of the penetrating agent in permeation. Higuchi then built upon this 
model to lead to another seminal paper, published in 1961, entitled ―Rate of release of 
medicaments from ointment bases containing drugs in suspension‖. This paper provided an 
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elegant set of equations to describe the rate of release of drugs from an ointment (Higuchi 1961). 
The resultant equations, which describe fundamental relationships between release rates, drug 
concentrations, diffusion coefficients and lag times, lay the foundation of the modern theories of 
skin permeation. The role of physical chemistry in the percutaneous absorption process was 
further emphasized by Blank and Scheuplein (Blank 1965; Blank et al 1967; Blank 1967; 
Scheuplein et al 1969; Scheuplein & Blank 1971a).  Since then, a large number of efforts have 
been dedicated to describe various aspects of skin permeation. These models vary tremendously 
in scope, ranging from simple models that consider the SC (or sometimes the entire skin) as a 
single compartment to those that explicitly consider the structural complexity of the skin (e.g., 
the lipids, the corneocytes, or the keratin within the corneocytes).   
 
 This review summarizes the key developments in predictive modeling of skin permeation 
over the last 50 years and also looks to the future so that such approaches are effectively 
harnessed for the development of better topical and transdermal formulations and for improved 
assessment of skin exposure to toxic chemicals.   
 
2. STEADY-STATE MODELS 
 
The fundamental equation to describe skin transport under steady-state conditions when a 
skin membrane is exposed to a solute on one side can be given by Fick‘s first law. It simply 
relates the amount of solute, Q, crossing the skin membrane of area, A, over a time period, T, 
with the constant concentration gradient across the two interior surfaces of the skin, Cs, the 
diffusion coefficient in the skin membrane, D, and the path length, h, as follows: 
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Q=DATCs/h      [1] 
The fundamental assumptions of Eq. 1 are that the skin barrier, SC, behaves like a pseudo-
homogenous membrane, and that its barrier properties do not vary with time or position. It is 
important to recognize that steady state can only be reached after the lag time for solute 
diffusion, which, for diffusion across a homogenous membrane is given by h
2
/6D, has passed. 
The lag time can be estimated from the x-intercept of the linear portion of the plot depicting 
cumulative solute permeation as a function of time. Equation 1 is frequently expressed in terms 
of steady-state skin flux, Jss, defined as: 
 Jss= Q/(AT)=DCs/h     [2] 
Higuchi, in his forward looking article, expressed this flux more appropriately in terms of 
thermodynamic activity as rather than widely used concentration approximation (Higuchi 1960). 
Clearly, the maximum flux, Jmax, will be seen when maximum solubility Ss of a solute in the SC 
is achieved, so that Eq. 2 can be written as: 
    Jmax=DSs /h      [3] 
The thermodynamic activity for any given solute is generally defined by the fractional solubility 
of the solute in the skin (Cs/Ss). However, nonlinearity can arise as a result of solute-skin and 
solute-vehicle non-ideal interactions (Roberts MS 2002). In practice, such non-idealities are less 
likely at lower concentrations and it is more convenient to express concentrations in terms of the 
solute concentration in the vehicle (Cv) and a partition coefficient, K, of the solute between the 
skin and the vehicle as follows: 
    Jss=KDCv/h      [4] 
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Where K =Cs/Cv. In this section, we apply and further develop these principles to demonstrate 
the predictive value of mathematical models of skin permeability in defining the absorption of 
therapeutic and toxic compounds through the skin. 
 
2.1 Quantitative structure-permeation relationship (QSPR) models 
Since the ground-breaking work of Scheuplein and Blank (Blank et al 1967; Blank 1967; 
Scheuplein 1967; Scheuplein & Blank 1971b), who were the first to properly quantify the rate 
and extent of percutaneous absorption of diverse chemicals, mainly from aqueous solutions, 
considerable efforts have been devoted to the establishment of relationships between the 
molecular properties of solutes and skin permeation (Geinoz et al 2004).  The objectives of such 
work have been broad, ranging, for example, from the identification and screening of potential 
drug candidates for transdermal delivery (Hadgraft 2003) to the assessment of potential risk 
following dermal exposure to hazardous chemicals, such as pesticides (Bouwman et al 2008). 
The main focus of quantitative structure-permeation relationships (QSPRs) has been the 
assessment of a permeability coefficient (usually designated by kp) which is defined as the 
steady-state flux of chemical across the skin (Jss) normalized by the concentration gradient, Cv: 
ss
p
v
J
k
C

     [5]
 
Often the concentration of the chemical is essentially zero on one side of the skin and kp is then 
the ratio of Jss and Cv.  By describing the skin as a single pseudo-homogenous membrane, it can 
be easily shown from Eq. 5 that kp is defined as (Crank 1975): 
h
DK
k p

      [6] 
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By assuming that the SC is the rate limiting barrier, which is often the case, and by using h as the 
thickness of the SC, then K and D in Eq. 6 describe the partitioning and diffusion in the SC 
treated as a pseudo-homogeneous membrane.  
 
Knowledge of kp, coupled with the chemical‘s saturation solubility in the vehicle in 
which it contacts the skin (Cv,sat), permits an estimation of the maximum flux (Jmax) of the 
molecule across the barrier: 
satvp CkJ ,max    
  [7] 
When applying Eq. 7, it is important to note that kp and Cv,sat must be determined in the same 
vehicle; one cannot combine an aqueous kp with a non aqueous Cv,sat. Clearly, Jmax is an 
inherently more useful and practical parameter when evaluating the potential therapeutic benefit 
or toxicological risk of a topically or transdermally absorbed substance (Kroes 2007).  
 
The vast majority of QSPR models provide algorithms to calculate kp when the vehicle is 
assumed to be aqueous. This has happened for two principal reasons: First, over time, a 
substantial database of experimentally determined kp values from aqueous vehicles has built up, 
allowing theoretical predictions to be directly compared with real measurements. Second, a 
physicochemical parameter that enables estimation of K is likely to be necessary for utilizing any 
algorithm developed for the calculation of kp.  The most obvious candidate in this regard is the 
octanol-water partition coefficient, P, values of which for many thousands of chemicals are 
available in the literature (or readily calculable using any number of approaches) (Leo et al 1971; 
Sangster 2010). 
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  A combination of Eqs. 6 and 7 gives a more fundamental definition of Jmax based on the 
permeant‘s solubility and diffusion coefficient in the SC: 
satSCC
h
D
J ,max       [8] 
The limitation of Eq. 8 is that D/h and CSC,sat are not easily determined by experiment. Instead, 
Kasting et al. (Kasting 1992) provided two insightful steps to render the expression much more 
useful.  First, it was proposed that CSC,sat might either be calculable from ideal solution theory, or 
estimated from the saturation concentration in model lipid solvents that mimic the SC, such as 
octanol or isopropyl myristate (Corg).  Second, given that the lipids of the SC are highly ordered, 
the diffusional barrier was treated as a semisolid, like a polymeric membrane. Molecular 
transport was then considered to proceed via a ‗free volume‘ mechanism, permitting the SC 
diffusivity to be modeled by Eq. 9 (Potts & Guy 1992): 
)exp(0 VDD        [9] 
where V is the molecular volume of the permeant, and D0 and β are constants. With these 
modifications, Eqs. 8 and 9 could then be combined to produce a QSPR (Eq. 10) that is in good 
general agreement with experimental results (Figure 1)(Cooper 1987). 
   ]303.2/[)/log()/log( 0max VhDCJ org      [10] 
Potts and Guy (Potts & Guy 1992) built upon this line of thinking and combined Eqs. 6 and 9 to 
give an expression for kp as follows: 
]303.2/[log)/log(log 0 VKhDk p      [11] 
which they then wrote more generally as: 
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    MWcPbak p  loglog    [12] 
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Figure 1: Experimentally determined maximum fluxes of chemicals normalized by their respective 
octanol solubilities plotted as a function of molecular volume (redrawn from (Cooper 1987)). 
 
Key assumptions made while deriving Eq. 12 are that the SC-water partition coefficient could be 
replaced by a function of P and that molecular volume could be approximated by the chemical‘s 
MW (Potts & Guy 1992). Values of P are available for many thousands of chemicals in the 
literature or can be readily estimated using a number of approaches (Leo et al 1971).  Potts and 
Guy then took advantage of a large compilation of published skin permeability coefficients from 
aqueous solution (Flynn 1990) to generate a QSPR that is now the most cited and applied QSPR 
model for predicting skin permeability: 
    plogk =-6.3 +0.71logP-0.0061MW   [13] 
where the units of kp are cm∙s
-1
. The experimental values used to derive Eq. 13 encompassed 
chemicals with MWs ranging from 18 to over 750 and log P values from -3 to +6.  The r
2
 of the 
multiple regression was 0.67 suggesting that approximately two thirds of the variability in the 
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data was explained by the model. In writing Eq. 13, the rate-limiting transport barrier of the skin 
is implicitly assigned to the lipophilic SC and, as a result, it will generate unfeasible values of kp 
for compounds that are extremely lipophilic. Acknowledging that the percutaneous absorption of 
such molecules is controlled by the underlying, more-aqueous-in-nature, viable epidermis (as 
had been deduced much earlier (Michaels et al 1975)), Cleek and Bunge (Cleek & Bunge 1993) 
derived an expression for estimating kp that places an upper limit for highly lipophilic species: 
 1 1400

  
padj
p
p
k
k
k MW
    [14] 
where 
pk is the permeability coefficient predicted by QSPRs for the SC from a water vehicle 
(with units of cm s
-1
); for example, from Eq. 13. Comparison between experimental percutaneous 
absorption fluxes and those calculated using the Potts and Guy algorithm and the Cleek and 
Bunge adjustment is illustrated for 14 compounds in Figure 2 (Guy 2010).  
 
Several QSPRs have been proposed that build on the form of Eq. 13 (Abraham et al 
1997; Abraham et al 1999).  For example, the partition coefficient, K, can be more explicitly 
represented in terms of the compound‘s molecular volume, polarisability, hydrogen bond donor 
and acceptor activities and molar refractivity. Incorporating such additional sophistication can 
result in improved fits of the model to (typically) more limited datasets (Potts & Guy 1995). 
Additionally, QSPR equations with complicated molecular structure descriptors offer the 
potential for better mechanistic understanding. However, some of the literature kp values used in 
these regressions may be anomalous (Degim 1998) or inconsistent with measurements from 
other laboratories (Vecchia & Bunge 2002b). Also, the ionization state of the compound in the 
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aqueous solution often is unclear, which will impact the permeability coefficient (kp) calculated 
from the flux data. When these factors are combined with the inherent variability in experimental 
measurements of skin permeation (Southwell 1994), especially for those chemicals that penetrate 
poorly (typically molecules with low lipophilicity and/or high MW), the introduction of more 
complicated molecular structure descriptors often cannot be justified from a statistical point of 
view. Moreover, regression to more complex models may provide misleading mechanistic 
insight and over-interpretation of the data (Geinoz et al 2004).   
Periodically, several of the published QSPRs have been comprehensively reviewed (Lian 
et al 2008).  A detailed examination of 33 QSPRs was conducted in 2008 (Bouwman et al 2008) 
using a set of defined criteria for acceptability, which was met by four models (ten Berge ; 
McKone 1992; Moss & Cronin 2002; Magnusson et al 2004b); three of these were based upon 
the octanol-water partition and molecular weight. Notably, the substitution of MW for V in QSPR 
equations succeeds because MW/V is nearly constant (at approximately 0.9 g/mL) for most 
compounds (mostly hydrocarbons) in the databases used to develop the various QSPR equations 
(Vecchia & Bunge 2002b). However, using these QSPR equations for chemicals with 
significantly larger MW/V (e.g., halogenated chemicals) produces kp estimates that are 
systematically low, but can be readily improved by adjusting the MW by the liquid density 
divided by 0.9 g/mL (Vecchia & Bunge 2002b). For example, using the adjusted MW of 63 for 
dibromomethane in (MW = 174, specific gravity = 2.497) in the QSPR equations provided better 
kp estimates. 
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Figure 2: Comparison between experimental Jmax values of various chemicals and those 
predicted using the Potts and Guy algorithm (Eq. 13) and corrected with the Cleek and 
Bunge equation (Eq. 14).  The ratios of measured to theoretical values fall within the range 
0.13 to 4.49; that is, well within an order of magnitude of the ‘ideal’ value of 1 (Guy 2010). 
While a majority of QSPR models try to predict kp, it is the Jmax that is a more practically 
relevant parameter. It can be estimated using experimental values of the aqueous saturation 
concentration along with kp calculated from a QSPR model for an aqueous vehicle. Alternatively, 
a quantitative structure-activity model can be used to predict values for Cv,sat that are used in Eq. 
7. Using a third strategy, Magnusson et al. developed a QSPR model for Jmax, rather than kp. 
(Magnusson et al 2004a) Interestingly, in this approach log P becomes a less significant 
parameter compared to that in kp-based QSPR models, and MW alone is sufficient to describe the 
bulk of the chemical-specific variation in the data. In later work, Zhang et al. showed that Jmax 
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does show a parabolic, or even better, a bilinear relationship with lipophilicity for similar sized 
solutes (Zhang et al 2009). They showed that the relationship reflected the variation in stratum 
corneum solubility for the various solutes and that the diffusion constant was relatively constant 
across the series. 
Research into the development of improved QSPRs continues. The strategies employed 
have sometimes been quite novel, and have brought new tools to bear on the problem.  Such 
approaches include chemical structure-based approaches, for example, fragment descriptor and 
neural network-based modeling approaches using large pools of theoretical molecular descriptors 
(Katritzky et al 2006; Baert et al 2007; Luo et al 2007; Neely et al 2009), ensemble modeling 
using nearest-neighbor theories (Neumann et al 2006), topostructural, topochemical, shape 
and/or quantum mechanical indices (Basak et al 2007) and Gaussian process models (Lam et al 
2010). Such approaches, though novel, have yet to find significant, ―real-world‖ application.   
 
While acknowledging that QSPRs are of enormous benefit, it must be realized that they 
have certain limitations. Perhaps most notably, they cannot be used when formulation 
components modulate the barrier properties of the skin. Extrapolation of the predictions from 
simple aqueous solutions to complex multi-component and/or multiphasic formulations is elusive 
and may be unachievable in some cases, although strategies that utilize experimental 
measurements of partial pressure (or other measures of thermodynamic activity) combined with 
maximum flux estimates show promise (Kurihara-Bergstrom et al 1986; Frasch 2010). 
 
2.2. Structure-based models  
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Steady-state solute flux across the SC can be described by Eq. 2. This equation adequately 
describes diffusion across a homogeneous medium. Hence, as long as the corresponding 
parameters (diffusion coefficient, partition coefficient and diffusion length) are averaged over the 
entire SC and the microtransport processes within the SC are rapid compared to diffusion across 
the membrane (Brenner & Edwards 1993), Eq. 2 adequately describes permeation across the SC. 
In reality however, the structural heterogeneity of the SC and the likely presence of slow 
reversible binding phenomena make it immediately clear that such averaging, in spite of offering 
mathematical simplicity, does not always accurately represent the diffusion process in the SC. 
Accordingly, efforts have been put forth to account for the structural complexity of skin.  
 
The SC consists of several layers of corneocytes (the bricks) with the space between them 
filled with lipids (the mortar), organized in the bilayer form. In one extreme scenario, it is 
assumed that the solute diffuses exclusively through the lipid region of the SC, which is the only 
continuous phase in the SC. This assumption is particularly applicable for highly lipophilic 
compounds, which partition almost completely into the lipid regions of the SC. Initial efforts to 
account for structural details of skin using mechanistic ―brick-and-mortar‖ models were 
described by (Chandrasekaran et al 1978). Since lipids occupy only a small fraction of the SC 
area, the actual area available for diffusion is much smaller than the macroscopic skin area. 
Furthermore, permeants have to follow a tortuous path around the corneocytes to cross the SC 
(Figure 3). Taking this into consideration, the steady-state permeability of the SC can be 
expressed as follows:  
lip lip
p
lip
D K
k
h

      [15] 
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where, Dlip is the solute diffusion coefficients in the SC lipid bilayers, Klip is the solute partition 
coefficient between the SC lipid bilayers and the vehicle and hlip is the effective diffusion path 
length of the permeant in the SC lipids, which is longer than the actual thickness of the SC and  
accounts for the fact that only a small fraction of the SC is occupied by lipids. The challenge is 
now shifted to determination of the parameters in Eq. 16. Numerous efforts have been dedicated 
towards this goal. A summary of these efforts is provided in section 4.  
 
Figure 3.  Schematic diagram for a brick-and-mortar model of the SC redrawn from 
(Johnson et al 1997a).  Key model parameters are the corneocyte aspect ratio,  = d/t; the 
lipid/corneocyte thickness ratio,  = g/t; and the offset ratio,  = d
l
/d
s
.  
 
In reality, however, solutes may be able to enter the corneocytes and their diffusion 
through the corneocytes may contribute substantially to the overall permeation. Models have also 
been developed to allow solute diffusion through corneocytes (Nitsche et al 2006b; Wang et al 
2006b; Wang et al 2007). These models, however, add considerable complexity to the 
calculation. They require additional parameters including diffusion and partition coefficients in 
the corneocytes, diffusion path length in corneocytes and mass transfer rate from lipids into 
corneocytes. Addition of this complexity to the model is justified when diffusion through 
conrnocytes contributes substantially to the overall permeability of the SC. In principle, the 
d
t
g
d
ldss
h
sc
(N layers)
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possibility of solute penetration into corneocytes can be incorporated into the model by using a 
generalized equation to describe SC permeability as follows: 
SC SC
p
SC
D K
k
h
      [16] 
where, DSC is the average diffusion coefficient in the SC, KSC is the average partition coefficient 
in the SC and hSC is the average diffusion path length in the SC. This simplification again 
requires that the premises of effective medium theory are satisfied, notably that the 
microtransport and binding processes are much more rapid than macroscopic diffusion. 
Structural features of the SC can then be incorporated into the model by determining KSC as the 
spatially-averaged value of partition coefficient in lipids and corneocytes (discussed in section 
4). This, in combination with appropriate solution of the microtransport problem (also discussed 
in section 4) provides a numerical value of kp from which an effective value of DSC can be 
calculated. Wang et al. provided such an algorithm to determine the magnitude of the 
contribution offered by solute penetration into the corneocytes (Wang et al 2006b).  
 
2.3. Porous Pathway model 
In general, equations based on permeation through lipids adequately describe the permeation of 
lipophilic drugs across the SC; however, their applicability to hydrophilic drugs may be 
inappropriate. Accordingly, attempts have been made to develop models to describe the transport 
of hydrophilic molecules. Similar attempts made by virtue of the QSPRs were described in 
section 2.1. Here, we describe additional considerations.  
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Appendages (hair follicles and sweat ducts) are a likely pathway for permeation of 
hydrophilic solutes. Analysis of solute permeation through appendages has been reviewed in the 
literature (Meidan et al 2005) and is not discussed in detail here. However, appendages are 
unlikely to explain the entire transdermal transport of hydrophilic solutes. The average density of 
hair follicles in human skin is about 50-100 per cm
2
 (Walters & Roberts 202; Scheuplein & 
Blank 1971b) and the area fraction occupied by the follicles is about ~10
-3
. The majority of hair 
follicle area is occupied by the hair shaft. The sweat glands occupy an area fraction of about 10
-4
 
(number density of 100-200 per cm
2
). Assuming a solute diffusion coefficient through 
appendages of ~10
-6
 cm
2
/s and an available area fraction of appendages of 10
-4
, the contribution 
of appendages to skin permeability is of the order of 10
-6
 cm/hr (Simmonin 1995). However, 
many hydrophilic solutes permeate skin at a much faster rate (Mitragotri 2003a). 
 
Ghanem and Peck introduced a model termed as porous pathway model to address this 
challenge (Peck et al 1994b). Several studies have subsequently built upon this model (Hatanaka 
et al 1990; Kim et al 1992; Morimoto et al 1992; Ruddy & Hadzija 1992; Dinh et al 1993; 
Yoshida & Roberts 1993; Peck et al 1994a; Lai & Roberts 1998, 1999). The general expression 
for permeability based on the porous pathway, kp of a hydrophilic permeant is given by: 
pore
D
p
k
p x




                                            [17] 
where , , and x are the porosity, tortuosity, and thickness of the membrane, respectively, and 
pore
pD  is the diffusion coefficient of the permeant in the liquid-filled pores within the membrane. 
According to the hindered transport theory, porepD  is a function of both the permeant and the 
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membrane characteristics. porepD  was expressed as a product of the permeant diffusion coefficient 
at infinite dilution and permeant diffusion hindrance factor (Tang et al 2001a), which depends on 
the pore size. A number of reports of estimated pore size can be found in literature, all of which 
are based on hydrodynamic hindered transport theory (Deen 1987). Pore radii reported by 
various researchers typically range from 10-30 Å (Ruddy & Hadzija 1992; Yoshida & Roberts 
1992; Dinh et al 1993; Yoshida & Roberts 1993; Peck et al 1994a; Li et al 1997; Higuchi et al 
1999; Manabe et al 2000; Tang et al 2001b; Tezel et al 2002; Polat et al 2010; Polat et al 2011). 
Tezel et al. reported that the pore size has a distribution and more than 99% pores possessed a 
radius smaller than 100 Å (Tezel et al 2003). A few estimates of SC porosity and pore density 
have been reported in the literature, all of which are based on model calculations and range from 
10
7
-10
9 
pores cm
-2
 (Pikal 1990; Kontturi & Murtomaki 1994; Mitragotri 2003b).  The resultant 
simplified, approximate equation describing skin permeability to small hydrophilic solutes based 
on porous pathway theory can be given by the following:  
 21.2 10 exp 1.5Pk r
  
    [18]
 
where, r is solute radius in Angstroms and kp is in cm/hr. Incorporation of porous pathway to 
describe transient permeation through skin has also been performed (Kushner et al 2007). In 
spite of success in describing the permeability of highly hydrophilic solutes, the use of the 
porous pathway theory to describe solute permeation has proved controversial largely due to lack 
of a connection between pores and skin structure. Specifically, relationships between estimated 
pore radii and pore densities and skin morphology have not been demonstrated. 
 
3. TRANSIENT MODELS  
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The previous section emphasized steady state permeability across a membrane beyond the 
diffusion lag time (Eq. 2). In this section, we examine the time dependency of skin penetration 
and the various models used to describe them.  
 
3.1. Basic models  
 
The fundamental equation describing transient drug diffusion across the SC is given by Fick‘s 
second law as follows:  
2
2
C C
D
t x
 

        [19] 
where C is the concentration of the permeating solute at time t at depth x within the skin. Key 
assumptions of Eq. 19 that are (a) the SC behaves like a pseudo-homogenous membrane, and (b) 
the diffusion coefficient and partition coefficient do not vary with time or position. To solve Eq. 
19, the starting concentration C within the SC as well as the conditions for concentration or flux 
at the boundaries of the SC (i.e., at the outermost and inner most surfaces of the SC) must be 
specified. It is more convenient to modify Eq. 19 in terms of concentrations in the vehicle, as 
defined by a partition coefficient K of the solute between the skin and the vehicle. Accordingly, 
the partition coefficient K, which is absent in Eq. 19, will usually appear in one or both of the 
boundary conditions. Different solutions are obtained for different starting values of C and the 
boundary conditions. The parameters such as D and K required to solve Eq. 19 are generally the 
same as those discussed in section 2.2 and are discussed in section 4. Mathematical challenges 
associate with finding solutions are discussed in section 5. 
 
3.2  Compartment models 
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Compartment models, also called pharmacokinetic (PK) models of skin, are often used to study 
the fate of chemicals entering and leaving the body. In combination with pharmacodynamic 
models relating concentration to the desired health effect, these PK models are potentially useful 
tools for risk assessments and predictions of transdermal drug delivery. These models treat the 
skin and also the body as one or several well-stirred compartments of uniform (average) 
concentration that act as reactors and/or reservoirs of chemical storage with transfer between the 
compartments depicted by first-order rate constant expressions. While permeation across the skin 
can be described using Eq. 19, it is often represented in a PK model as either a series of 
compartments to mimic the partitioning and diffusion processes in the stratum corneum or as one 
compartment and two compartments that separately distinguish the lipophilic SC and hydrophilic 
viable epidermis layers of the skin (Roberts & Anissimov 2005).  A differential mass balance of 
chemical in the one-compartment skin layer produces the following equation: 
   
 skinskin 1 v 1 skin 2 skin 2 b
d
d
    
C
V k C k C k C k C
t
 [20] 
where 
skinC is the position-averaged drug concentration in the skin layer, Vskin is the volume of 
the skin layer, and kj (j = 1, -1, 2 and -2) are the rate constants describing drug transfer between 
the vehicle, skin and blood compartments. Variations of the concentration in the vehicle (Cv) and 
the concentration in the blood (Cb) are described by mass balances for these compartments 
including links to additional compartments representing the various tissues and metabolic 
process in the body. The two-compartment model of skin is given by: 
sc
sc 1 v 1 sc 2 sc 2 ve
d
d
C
V k C k C k C k C
t
      [21] 
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ve
ve 2 sc 2 ve 3 ve 3 b
d
d
C
V k C k C k C k C
t
      [22] 
where 
scC and veC are the position averaged concentrations in the SC and viable epidermis, 
respectively.   
 
The advantage of using compartment models for skin is that the mathematical solution of 
even complex exposure situations (e.g., periodic exposures and evaporating solutions) combined 
with variable distribution and metabolism in and elimination from the body as well as variations 
in blood flow to the skin are represented by first-order differential equations that are easily 
solved by a number of standard software packages. These models are also simple enough to 
conduct probabilistic calculations allowing an assessment of the effects of variation in the system 
parameters. 
 
In many papers with skin compartment models, the rate constants describing transfer to 
and from the skin compartment(s) have been determined by fitting to experimental data without 
relating the result to the parameters of skin (e.g., kp, D, K, and h). Because variations of 
concentration with position are not described by compartment models, they cannot match all 
aspects of the behavior predicted by Fick's second law for a membrane with the same physical 
properties. It follows that different definitions of rate constants in terms of the skin parameters 
can be developed that match the behavior of the membrane model for different conditions 
(McCarley & Bunge 1998; Reddy et al 1998; McCarley & Bunge 2000). In a review of several 
one- and two-compartment models with rate constants expressed in terms of skin parameters, 
McCarley and Bunge have identified the underlying assumptions (including specified methods 
for estimating input parameters), and discussed how these affect the model‘s performance 
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(McCarley & Bunge 2001). Recently, the effect of the compartment model definitions on dermal 
absorption prediction was assessed by comparing model predictions with in vivo human 
experiments in which skin absorption of chloroform was determined from breath concentrations 
(Norman et al 2008).  
 
3.3 Complex models 
 
While most attention in the field of modeling of skin permeation has been focused on describing 
diffusion processes in the SC, it has been recognized that additional processes including binding 
and metabolism (Liu et al 1994) also play an important role in determining drug uptake. Binding 
is especially significant since many substances bind to keratin, which significantly influences 
their permeation across the SC.  
 
Slow binding/partitioning kinetics in the SC 
 
The effect of binding on transdermal transport in the context of the epidermal penetration has 
been discussed by Roberts et al (Roberts et al 2002), where the kinetics associated with the 
reservoir effect of the stratum corneum was considered. It was assumed in this work that binding 
is instantaneous, that is equilibration between bound and unbound states is fast compared to 
diffusion. The advantage of such an approach is that the modeling in this case is relatively simple 
with the diffusion coefficient (D) in the diffusion equation being replaced by an effective 
diffusion coefficient (Deff), where Deff=fuD and fu is the fraction of solute unbound. As the 
fraction unbound is less than unity, binding leads to slower diffusion, and therefore longer lag 
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times. If binding/partitioning is not fast compared to diffusion, the single diffusion equation has 
to be replaced by coupled partial differential equations: (Anissimov & Roberts 2009a)  
boffuon
uu CkCk
x
C
D
t
C






2
2
   [23]
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

     [24]
 
where Cb and Cu are concentrations of bound and unbound solutes, D is the diffusion coefficient 
of the unbound solute (bound solute is assumed immobile, or its diffusion is so slow that it can 
be neglected) and kon and koff are binding and unbinding rate constants. Taking Laplace transform 
of these equations and expression of ˆbC using 
ˆ
uC  yields: 
2
2
ˆ
ˆu on
u
off
d C sk
D s C
dx s k
 
         [25]
 
It can be noted that the only difference with the simple diffusion equation in the Laplace domain 
is that s is replaced by a function ( )g s , where; 
( ) on
off
sk
g s s
s k
 

       [26]
 
Thus equations for the unbound concentration and flux through SC can be obtained by replacing 
s  with ( )g s  in the above equations. It has been demonstrated (Anissimov & Roberts 2009a) that 
modeling of penetration experiment is less affected by slow equilibration as compared with that 
of the desorption experiments. It is also reasonable to assume that experiments with finite donor 
doses will be significantly affected by slow equilibration, as later stages of the finite donor 
experiments resemble desorption processes. The slow equilibration in the SC has a pronounced 
effect in skin reservoir formation and needs further experimental investigation.  
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Using a physical model approach, Ando and co-workers developed equations to describe 
situations where simultaneous metabolism and transport of drugs occur in the skin (Ando et al 
1977). Two situations were investigated. In the first situation, the drug was placed on the dermis 
side of a diffusion cell and did not penetrate the stratum corneum. In the second situation, the 
drug, placed on the epidermis side, penetrated the stratum corneum and then passed through the 
metabolizing epidermis. Expressions for determining the metabolic rate constant from 
experimental data along with concentration profiles and flux expressions were derived both for 
the drug and its metabolite. A model which required computer simulation and which 
incorporated non-uniform enzyme distributions, as well as composite membranes with many 
layers was later developed  by the same group (Fox 1979). 
 
 These models did not consider metabolism in the stratum corneum but mathematical 
expressions derived by Hadgraft (Hadgraft 1980b) using an idealized physical model, took into 
account  metabolism both in the upper and lower layers of the epidermis. Two routes of 
penetration were considered, firstly when the drug diffuses straight through the cells and 
secondly when the substrate passes through the intercellular channels. Hadgraft and Guy 
expanded the earlier physical model approach described by Hadgraft to incorporate Michaelis-
Menten kinetics (Guy & Hadgraft 1982).  
 
Liu and co-workers described a theoretical model to predict permeant transport across the 
skin for the situations in which there is significant co-transport of an enhancer solvent along with 
the principal permeant (Liu P 1992). The model successfully predicted the effects of 
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simultaneous transport of ethanol on metabolism and diffusion of -estradiol in hairless mouse 
skin. Bando et al. developed a two-layer diffusion model which incorporates both polar and non-
polar pathways and where metabolism in the viable layer was considered (Bando H 1996; Bando 
H 1997 ). Assuming first order metabolism kinetics, Laplace transformed equations were 
obtained to describe skin permeation of drug and metabolite.  
 
 Kretsos et al. developed a distributed diffusion-clearance model to take account of the 
spatial distribution of the vascular processes responsible for drug removal by the dermis (Kretsos 
et al 2004). This model quantifies molecular diffusion through the heterogeneous skin 
microstructure of the skin and characterizes vascular clearance as a volume-average clearance 
coefficient. More recently, a microscopic model describing the dermal capillary clearance 
process was described by Kretsos and Kasting (Kretsos & Kasting 2007). The model accounts 
for both convective-dominated transport in the capillaries as well as interstitial diffusion and the 
model was validated with published results for in vivo human skin permeation of hydrocortisone.  
 
4. ESTIMATION OF PARAMETERS 
 
A major issue in quantifying skin penetration and utilization of the models described in section 3 
is the assessment of the key parameters defining skin permeability, namely partition coefficient, 
diffusion coefficient and diffusion path length. In this section, we discuss estimation of 
parameters that are necessary to predict skin permeability. As can be seen from the discussion so 
far, the required number of parameters may vary depending on the complexity of the model. 
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Here, we focus on three key parameters that are most commonly required to predict skin 
permeability, that is, partition coefficient, diffusion coefficient and path length.  
 
4.1. Partition Coefficient 
Diffusion through skin involves partitioning between multiple phases; e.g. between the SC lipids 
and the vehicle, the corneocytes and the vehicle, between the lipids and the corneocytes, and 
between the SC and deeper skin layers (e.g., the viable epidermis).  In simple models describing 
partitioning into the SC from a vehicle, the multiphasic details of the SC are ignored, and the 
effective partition coefficient between the SC and the vehicle (Ksc/v) is estimated from structure-
activity algorithms relating experimental measurements of Ksc/v to one or more descriptors, logP 
being the most common (for example, see (Cleek & Bunge 1993; Roberts et al 1996) (Surber et 
al 1990a; Surber et al 1990b)) and the review by (Vecchia & Bunge 2002a): 
     /
b
sc vK aP      [27]
 
 
Typically, a has been reported to be close to 1, while b varies from about 0.4 to 0.9 depending on 
the data set used in the regression.  As for the QSPR, the partition coefficient can be represented 
in terms of more complicated molecular structure descriptors with modest benefit (Vecchia & 
Bunge 2002a).   
 
Expressions for estimating Ksc/v have also been derived that consider the individual 
contributions of the lipid and corneocytes (Nitsche et al 2006b). 
/ / /  sc v lip lip v cor cor vK K K    [28]
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where Klip/v is the lipid-vehicle partition coefficient, Kcor/v is the corneocyte-vehicle partition 
coefficient, and lip and cor are the volume fractions of lipid and corneocytes, respectively in the 
SC, which together sum to 1.  In this approach, expressions are then required for Klip/v and Kcor/v.  
 
Broadly speaking, two factors impact solute partitioning into lipid bilayers; a chemical 
factor which accounts for the fact that the environment in the lipid bilayers is more hydrophobic 
than the surrounding aqueous conditions and a physical factor, which accounts for the fact that 
lipid chains in the bilayer are highly organized, thus reducing the partition coefficient due to low 
free volumes (Egberts et al 1994; Tieleman et al 1997). The complexity of the physical 
contributions to partition coefficients has been reported for phospholipid bilayers based on 
molecular simulations and experimental measurements. For the phospholipids, organization of 
the lipid tails has been shown to vary substantially with the depth within the bilayer  (Egberts et 
al 1994). Because the chains are more loosely packed near the center of the bilayer, solutes tend 
to partition preferentially near the bilayer center compared to near the head group (Marrink & 
Berendsen 1994; Mitragotri et al 1999). Extension of these findings to SC lipid bilayers has been 
challenging owing to their greater chemical and structural complexity; however recent studies 
have reported remarkable progress in this direction (Notman et al 2007b; Notman et al 2007a; 
Notman et al 2008; Das et al 2009). A statistical mechanical theory, called scaled particle theory 
has been utilized to simplify utilization of molecular details of structures in predicting skin 
permeability (Mitragotri 2002). This theory revealed that the contribution of physical factors, 
such as chain packing, is relatively small, especially when compared to the complexity that it 
adds to the calculations. Consistent with strategies for developing QSPR, it is reasonable to 
assume that the partition coefficient of a solute from water into SC lipids is comparable to that 
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into an isotropic solvent that reasonably mimics the chemical environment in the SC lipids. 
Several solvents including octanol, hexadecane, olive oil, butadiene, and dodecadiene, have been 
used as model solvents for SC lipids (Raykar et al 1988; Anderson & Raykar 1989; Xiang & 
Anderson 1994; Johnson et al 1997b; Yamamoto & Liljestrand 2004; Kwon et al 2006; Nitsche 
et al 2006a), although octanol is the most convenient for reasons discussed earlier (Johnson et al 
1996).  
 
After subdividing the corneocyte partition coefficient in Eq. [28] into contributions from 
water and protein binding (i.e., cor =  pro + water, where pro and water are the volume fractions 
of proteins and water in the SC assumed to only exist within the corneocytes), Nitsche et al. 
(Nitsche et al 2006b) derived the following expressions for partitioning from a water vehicle by 
regressing the octanol-water partition coefficient to a large set of experimental Ksc/w data 
according to the relationship described in Eq. [28] using the following expressions for the lipid-
water and corneocyte-water partition coefficients: 
    0.81
/ 0.35lip wK P      [29]
 
    
 
0.27
/
5.4
 



pro
cor w
pro water pro
P
K
w v
w v    [30]
 
In Eq. [30], wpro is the mass of protein per mass of dry SC (assumed to be 0.9), v is the mass of 
water in the SC per mass of dry SC (which varies with hydration), and water and pro are the 
densities of water and protein, respectively.  For nearly the same dataset used to derive Eqs. [29] 
and [30], Vecchia and Bunge (Vecchia & Bunge 2002a) determined a = 0.88 and b = 0.43 for an 
expression in the form of Eq. [27].  The expressions in Eqs. [29] and [30] can also be used in 
complex diffusion models of the SC, which require partition coefficients for the lipids and 
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corneocytes (Wang et al 2006a, 2007). Expressions have been derived to describe solute 
diffusion in dermis (Ibrahim & Kasting 2010), a topic that is not included in this discussion.  
 
4.2. Diffusion coefficient 
 
Diffusion coefficients in a composite, anisotropic medium like the SC must be carefully defined 
and judiciously applied. Passive transport across such a medium cannot always be defined in 
terms of a single diffusion coefficient, either because of the anisotropy or because the conditions 
for an effective medium description of the material are not satisfied (Brenner & Edwards 1993). 
The essential condition is that the time frame for equilibration of all microscopic processes must 
be much shorter than that for bulk transport across the system (Wang et al 2006a). Furthermore, 
the diffusion coefficient, like the partition coefficient, may change with concentration of the test 
material (Anissimov & Roberts 2004b), or in response to other chemical or physical perturbation 
of the system. A recently presented example in which a single diffusion coefficient does not 
describe transport in the SC is the absorption and desorption kinetics of water (Anissimov & 
Roberts 2009b).  This result was interpreted in terms of slowly reversible binding of water to 
keratin. The slow kinetics of this process relative to transport times across the tissue preclude the 
use of effective medium parameters to describe the result. As another example, lateral and 
transverse diffusion coefficients within the SC are anticipated to have different values due to the 
anisotropy of the tissue (Wang et al 2006a).  This discussion will focus on transverse diffusion 
across the SC, the problem of greatest interest for most applications. 
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The most common way to obtain the transverse diffusion coefficient of a permeant in the 
SC is from experimentally measured steady-state permeabilities in combination with an 
equilibrium partitioning experiment employing the same vehicle (Eq. 6).  Diffusion coefficients 
so obtained will work when employed in an identical manner, i.e., to estimate steady-state flux 
across skin from the same vehicle. They are not guaranteed to work for other vehicles or even for 
transient calculations from the same vehicle, as was shown by Frasch and Barbero (Frasch & 
Barbaro 2003).  This obviously limits their utility. Conversely, and for the same reasons, when 
diffusivities estimated from the lag time, tL, of steady-state permeation studies as h
2
/6tL are 
combined with experimental partition coefficient values, they may not yield accurate steady-state 
permeabilities. They have the advantage that the partition coefficient need not be known, but 
they have a disadvantage that experimental variability is high and may be complicated by 
swelling or shunt diffusion (Scheuplein 1967). 
 
All other estimates of diffusion coefficients in the SC are model-based.  They are only as 
good as the underlying model. Relative to values calculated from Eq. 6, they have the advantage 
of applying to a broader range of conditions including predictions for new permeants, if the 
model is valid.  This has inspired a great deal of effort to develop such models, a few of which 
are discussed below.  It is important to realize that the more complex models actually calculate 
flux under various conditions based on an underlying microscopic model. Below, we summarize 
some of the efforts put forth to describe diffusion coefficients in the SC. 
 
Potts-Guy Model:  The Potts-Guy Equation, in its commonly used form, is often referred to as a 
QSPR model; however the same equation has been rearranged to describe the diffusion 
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coefficient in the SC.  The resultant equation is a model for a homogeneous lipid membrane for 
which the diffusivity is described using a free volume-like expression (Kumins & Kwei 1968). 
  )exp(// 0 MWhDhD scscsc      [31] 
where D
0
/hsc = 10
-6.3
 cm/s, = -0.0061 and MW is the molecular weight of the permeant.  
Equation 31 captures the most essential feature of SC diffusivity – it is a strongly decreasing 
function of the molecular volume (or approximately the molecular weight) of the permeant.  The 
more complex microscopic models developed later in the field retain this essential feature. 
 
Johnson-Blankschtein-Langer Model:  Johnson and coworkers (Johnson et al 1997a) proposed 
that transdermal drug transport was dominated by lateral diffusion in the lipid layers (Figure 3).  
The lipids are anisotropic, but they are arranged such that permeants can travel across the SC 
without having to cross lipid headgroup regions (c.f. Model 1 in Ref. (Wang et al 2006a)).  The 
corneocyte phase was considered to be impermeable. The lateral diffusion coefficient was 
estimated by fitting Eq. 6 to experimentally measured skin permeabilities. The diffusion 
coefficients thus measured compared well to the experimentally measured diffusion coefficients 
in isolated SC lipids using Fluorescence Recovery After Photobleaching (FRAP) experiments on 
fluorophores (Johnson et al 1996). These lateral diffusion coefficients exhibit a strong 
dependence of diffusivity on molecular weight for small permeants and a weaker one for large 
permeants as derived from Saffman-Delbruck theory for diffusion of proteins in cell membranes 
(Saffman & Delbruck 1975). The theory captured several aspects of SC diffusion, but required 
an inordinately long path length through the SC (3.6 cm) to reconcile observed diffusive lag 
times. 
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Wang-Kasting-Nitsche model:  Wang et al. (Wang et al 2006a, 2007) proposed a composite 
model of the SC that retained a two-dimensional brick-and-mortar geometry similar to (Johnson 
et al 1997a), but allowed for a permeable corneocyte phase. Lipids were anisotropic, as in 
(Johnson et al 1997a), but two arrangements were considered (Figure 4).   
 
Figure 4.  Alternative topologies of the intercellular lipid phase according to Wang et al. 
(Wang et al 2006a) (a) Model 1, admitting bilayers that continue indefinitely from unit cell 
to unit cell without interruption. (b) Model 2, in which each corneocyte is completely 
surrounded by intact lipid bilayers; here progress from one layer of corneocytes to the next 
requires a transbilayer transport step.  
 
The lipid arrangement in Model 1 was similar to that described by Johnson et al. (Johnson et al 
1997a), but Model 2 required permeants to cross many headgroup regions in order to traverse the 
tissue.  A further elaboration was the addition of an SC hydration component to the model, so 
that both partially hydrated and fully hydrated SC could be represented.  The model describes 
three microscopic transport coefficients in the SC: a lateral lipid diffusivity, Dlat, a transverse 
mass transfer coefficient, ktrans, for hopping across lamellar bilayers, and an isotropic corneocyte-
phase diffusivity, Dcar.  A microscopic partition model is separately described (Nitsche et al 
2006b).  SC permeability was calculated from a finite difference representation of these models 
cast in terms of dimensionless parameters R and σ.  R is essentially the ratio of transverse to 
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lateral diffusion rates in the lipids, whereas σ is the ratio of lipid to corneocyte permeabilities.  
The permeability surfaces calculated by this approach are shown in Figure 5. Among the 
conclusions generated from this approach were that the SC lipids were highly anisotropic, with 
transverse mass transfer generally much slower than lateral lipid diffusion (Wang et al 2007). 
Furthermore, most permeants of interest for pharmaceutical or dermal safety evaluation 
permeated the SC in a predominately transcellular manner (Wang et al 2007). 
 
 
Figure 5.  Dimensionless SC permeability surface for the model described by Wang et al. 
(Wang et al 2007) (a) Model 1 and (b) Model 2.  In both parts, the (upper) surface defined 
by the mesh of thick lines represents swollen (fully hydrated) SC, and the (lower) gray 
surface with thin lines represents unswollen (partially hydrated) SC.  The dimensionless 
parameters R and σ are described in the text.  
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Mitragotri Model: Mitragotri put forth an equation to describe solute diffusion in lipid bilayers 
using Scaled Particle Theory. This statistical mechanical theory allows for solute diffusion in all 
directions within the lipids (trans- and lateral) and provides an average value. This theory 
calculates diffusion coefficient based on the amount of work required to create a free volume to 
allow for solute diffusion. The average diffusion coefficient in the lipid bilayer was given by Eq. 
32.  
 5 22 10 exp 0.46lipD x r       [32] 
where, r is the solute radius in Angtroms and Dlip is in cm
2
/s.  
 
4.3. Diffusion path length/tortuosity 
If the SC lipids comprise the primary route by which permeants enter and cross the tissue, then 
the geometry of the SC and the detailed arrangement of both corneocytes and lipids makes a 
great deal of difference in model calculations, as it affects the path length for diffusion.  This 
subject has been discussed extensively since the first development of brick-and-mortar models 
(Michaels et al 1975); it is a key aspect of lipid pathway models such as (Johnson et al 1997a).  
If, on the other hand, diffusion is primarily transcellular, then the lipid tortuosity factor is of 
secondary importance.  This is the position presented in  (Wang et al 2007).  Clearly, as the 
importance of corneocyte-phase transport is reduced, the impact of lipid tortuosity increases. 
 
A detailed discussion of lipid phase tortuosity has been presented by Frasch and Barbero 
(Frasch & Barbaro 2003) in their finite element analysis of the SC lipid pathway. They studied 
transient diffusion through model SC structures including both ordered and disordered 
corneocyte phases. In this particular analysis, the corneocyte phase was considered to be 
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impermeable, a restriction later relaxed (Barbero & Frasch 2006).  Frasch and Barbero found that 
diffusion in both the ordered and disordered SC models was well described by a homogeneous 
membrane model; however, both the effective diffusion coefficient, D*, and the path length, hsc*, 
were different from the input variables. For the ordered structure shown in Figure 3, hsc* is 
given by: 
 
)(* gtdNhsc  .       [33] 
The value of D* was not expressed so compactly; however, expressions for the flux and lag  time 
relative to a homogeneous membrane having the same microscopic lipid diffusivity D0 and 
thickness h0 were given. The results were: 
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Here α = d/t, σ = s/t, = t/(t+g) and ω = dL/ds.  Eq. 33 had been given previously by Johnson et 
al. (Johnson et al 1997a), and Eq. 35 has been corrected as discussed in (Frasch  & Barbero 
2004).  Equations 33 and 35 have been fully validated for the case of isotropic lipids and 
impermeable corneocytes (Frasch & Barbaro 2003). However, both of these assumptions are 
challenged in recent SC models (Wang et al 2006a, 2007). More recently, Kushner et al. reported 
a structure-based model with two tortuosity factors to account for the effect of branched, parallel 
pathways on the transport of hydrophobic permeants through the lipid bilayers of the stratum 
corneum. Both steady-state and transient solutions to Fick's second law were provided (Kushner 
et al 2007).  
38 
 
 
5. MATHEMATICAL APPROACHES 
 
The expression of transport of a solute across a skin barrier membrane involves a number of 
steps and phases in a space and time variant process. The formal description of this process as a 
single equation is not straightforward, other than as one or more approximations in definition of 
the transport conditions or in presentation of the solutions. Here, we begin with the conventional 
Laplace Transform approach used to solve diffusion equations, move to methods that allow 
variations in space and time in the transport process and various complexities to be better 
addressed. We conclude with a comment on how approximations may be used to summarize skin 
penetration data in the real world situation. 
 
5.1. Laplace Transform solutions 
Laplace transform is an integral transformation that is used to solve ordinary and partial 
differential equations. Its application to solving diffusion problems has been described in the 
well known book by Crank (Crank 1975) and by Carslaw and Jaeger for the analogous heat 
conduction problems (Carslaw & Jaeger 1959). In the notation common in the skin transport 
literature, Laplace transform of the C at x and t in the skin, ( , )C x t , is defined as:  
 
0
ˆ ( , ) ( , ) ( , ) stC x s C x t C x t e dt

  
    [36]
 
where designates the Laplace operator, s is the Laplace variable and the hat over the function 
(ˆ) denotes the Laplace transform. If the Laplace transform of a function is known it can be 
potentially inverted to time domain. Inverting back to time domain, however, is not trivial and 
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requires the knowledge of the theory of functions of a complex variable, although tables of 
Laplace transform (e.g.(Abramowitz & Stegun 1965)) often help the inversion process.  
 
The most useful property of the Laplace transform in the context of solving differential 
equations is that it converts time derivatives into algebraic functions of position and s, thereby 
reducing the partial differential diffusion equation into an ordinary differential equation that is 
much easier to solve. The Laplace transform of the diffusion equation, Eq. 19, yields: 
2
2
ˆ ˆ( , ) ( ,0) ( , ) 
d
sC x s C x D C x s
dx
       [37] 
where C(x,0) is the initial condition.  If the skin starts out without any chemical, C(x,0) = 0, Eq. 
37 has the general solution: 
ˆ( , ) ( )sinh ( )coshd d
x x
C x s A s st B s st
h h
   
    
   
   [38]
 
where h  is the thickness of the SC, 
2
dt h D  is the characteristic time of diffusion, and ( )A s
and ( )B s  are functions of only s, which are be determined from the boundary conditions and h  
is the thickness of the SC. Equation [38] can also be further manipulated to calculate the 
transdermal flux and cumulative drug transport. The use of Laplace transforms for mathematical 
modeling of skin transport was pioneered by Hadgraft (Hadgraft 1979, 1980a) and Guy and 
Hadgraft who used the solution in the Laplace domain (Guy & Hadgraft 1980) to derive long and 
short time approximations of the total amount of drug that penetrated in the time domain.  
 
The popularity of the Laplace transform in the skin literature has increased since the 
availability of scientific software (e.g. Scientist, MicroMath Scientific software) that can invert 
from the Laplace domain to the time domain and allowing regression to experimental data 
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without the extra work of first deriving a functional representation of the Laplace solution 
inverted into the time domain. With this type of software, having the Laplace solution is virtually 
as good as having solution written in terms of time. Anissimov and Roberts (Anissimov & 
Roberts 1999, 2001, 2004a, 2009a) have used the numerical inversion of Laplace transform 
solutions to the diffusion equation for simulations and data analysis of skin transport 
experiments. One of the useful properties of the Laplace transform is that it can be used directly 
(without inversion to the time domain) to determine some parameters. In transport through skin 
for the case of a constant donor concentration, such parameters are the steady-state flux and the 
lag time (Anissimov & Roberts 1999, 2001). 
 
While Laplace transforms offer numerous advantages in solving diffusion equations, they 
also suffer from certain limitations. Most notably, to be solvable by the Laplace transform, the 
partial differential equations have to have coefficients that are independent of C. Also, the 
coefficients in the differential equation (e.g., the diffusion coefficient in Eq. 19) have to be 
independent of time (e.g. constants or functions of x only) for the Laplace transform to convert 
the partial differential equation into an ordinary differential equation of x only. This excludes 
important classes of problems in skin transport that involve the diffusion coefficient changing 
with concentration or time. For example, co-diffusion with a penetration enhancer or a diffusion 
coefficient that changes due to skin drying.  
 
5.2. Finite Differences solutions 
The finite difference approach to solving a differential equation or a system thereof involves 
replacing the differential equation with a set of difference equations that cover the requisite 
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space. There are many variations to this theme, the sophistication of which depends upon the 
problem to be solved.  The most common difference approximations are centered differences, 
i.e., equations centered in space at the location where the approximation is made. As an example, 
the one-dimensional diffusion equation,  













x
C
D
xt
C
      [39]
 
which is written to allow D to be a function of x or a function of C, which is a function of x, 
becomes, after differencing in space: 
     12/12/12/112/1
2
  iiiiiii
i CDCDDCD
dt
dC
x , i  =  2, ..., N-1 [40] 
Here the region in space governed by Eq. [40] has been subdivided into N equally spaced layers.  
In this scheme the concentrations Ci are defined at the center of each layer and the diffusivities 
DIi ½ are defined at the edges of the layers.  The layers i = 1 and i = N require special treatment 
because they incorporate the boundary conditions for the problem.  This differencing scheme 
transforms the partial differential equation into a set of N ordinary differential equations (ODEs).  
The system of ODEs may then be solved by standard techniques (Press et al 1992), most of 
which involve integrating difference equations in time.  A skin diffusion model employing Eq. 
40 and a Crank-Nicolson time integration scheme is described in (Kasting et al 2008).  
 
 For systems involving widely varying distance scales, finite difference schemes with a 
variable spatial mesh have been developed.  The mesh spacing broadens in the center of a layer 
and becomes very fine at interfaces where transport properties are discontinuous.  Appropriate 
application of this methodology allows the development of extremely efficient integration 
routines with remarkable spatial resolution.  A masterful application of this approach to the SC 
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brick-and-mortar diffusion problem, conceived in large part by Prof. J. M. Nitsche, is described 
by Wang et al. (Wang et al 2006a, 2007). 
 
 Finite difference methods are particularly advantageous for potentially nonlinear systems 
with either simple geometry or periodic geometry.  Much of the efficiency is lost for disordered 
structures. Relative to finite element methods, finite difference methods can be much more 
efficient on periodic problems such as a regular brick-and-mortar SC structure. However, 
considerable skill is required to construct accurate approximations at boundaries and to 
implement an efficient variable mesh scheme.  Relative to Laplace transform methods, the 
biggest advantages of finite differences are the ability to handle nonlinear problems and more 
complex boundary conditions.  Both call for considerable skill by the operator. 
 
5.3. Finite Element Method Solutions 
The finite element method (FEM) is related to the finite difference method in that both offer 
approximate numerical solutions to linear or non-linear partial differential equations. The FEM is 
able to handle domains with complicated geometries and boundaries, including moving 
boundaries. The primary basis for the FEM is the discretization of a continuous domain of 
interest—here the skin—into a discrete set of connected subdomains. The resulting mesh of 
triangles or higher order polygons, referred to as elements, creates a finite dimensional linear 
problem whose solution can be implemented on a computer. In general, the density of the mesh 
varies across the domain, with greater density over those areas where greater precision in the 
solution is required. An example might be the regions in the stratum corneum near a boundary 
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between corneocyte and lipid domains. Owing to the complexity of the meshing and solution 
procedures, the FEM is frequently implemented using commercial software packages. 
 
 Rim et al. (Rim 2005) developed a finite element model consisting of two isotropic 
materials with different diffusion and partition coefficients, connected by an interfacial flux. The 
two materials are intended to represent a dermal patch or reservoir containing a drug of interest, 
and the skin. Addition of a permeation enhancer creates a coupled 2-component system with 
concentration-dependent diffusivities to account for interactions between drug and enhancer. In 
vitro experiments using a drug (fentanyl) and an enhancer (lauryl pyroglutamate) were used to 
examine the relative roles of enhanced diffusivity and partitioning. It was found that the latter 
more accurately accounts for the experimental observations, but the authors concede that other 
nonlinear processes may play a role. 
 
Heisig et al used a related method, finite volumes, to solve both transient and steady-state 
transport of drugs through a biphasic brick and mortar model of stratum corneum (Fig. 3) with 
isotropic lipids and permeable, isotropic corneocytes (Heisig et al 1996). This work 
demonstrated the contributions of corneocyte alignment, relative phase diffusivity, and phase 
partitioning in the barrier properties of the SC. Subsequent extensions in both 2-d (Naegel et al 
2008) and 3-d (Naegel et al 2009) skin models have been described, and the group has explored 
the role of drug binding to corneocyte elements on skin transport (Hansen et al 2009). The key 
finding is that steady-state binding data of lipophilic compounds can be described by a model 
that posits interaction with the cornified cell envelope. 
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 Frasch and Barbero (Frasch & Barbero 2003) analyzed a finite element model of the 
stratum corneum lipid pathway to investigate effective path length and diffusional lag times in 
this path compared with a homogeneous membrane of the same thickness. Results of this 
analysis have been described above. This group also presented a transcellular pathway model, 
whereby permeants are granted access to the corneocytes via a corneocyte-lipid partition 
coefficient and separate diffusivity within corneocytes compared with lipids. The authors 
compared modeled membrane lag times with in vitro measurements (n=27) for hydrophilic 
compounds gathered from the literature. Results pointed to a transcellular pathway with 
preferential corneocyte partitioning as the likely diffusional path for hydrophiles. Lag times in 
the lipid path model were too brief to account for measured lag times, whereas the transcellular 
route could account for them (Barbero & Frasch 2006). 
 
 A secondary result from these investigations was the observation that the complex 
disordered geometric representation of the stratum corneum could be reduced to a simple, 
rectangular brick-and-mortar geometry with very similar results (Barbero & Frasch 2005). 
Furthermore, for many realistic combinations of corneocyte/lipid partitioning and diffusivity, the 
short vertical connections between bricks can be ignored and the problem can be reduced to a 
multilayer a-b laminate model, where ―a‖ represents lipids and ―b‖ corneocytes. This 
configuration is a good representation for the transcellular path with preferential corneocyte 
partitioning. Thus for many purposes, the complex geometrical arrangement of the stratum 
corneum can be reduced to a much simpler geometry for which simpler numerical algorithms, 
such as the finite difference method, can be applied. In fact, analytical solutions for steady-state 
flux and lag time have been published for the multilayer laminate model (Crank 1975). 
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 Further refinement supports the idea of a ―pseudohomogeneous membrane‖ model of 
stratum corneum. This means that, for purposes of estimating macro-level time dependent 
variables such as flux and penetrated mass, a homogeneous membrane approximation can be 
made which eliminates the necessity of explicitly accounting for the complex geometrical 
configuration of the stratum corneum. This conclusion is bolstered by more formal analysis using 
the method of homogenization (Rim et al 2008). The parameters of this reduced membrane—
effective diffusivity, partition coefficient, and path length—can be estimated as described herein 
(Section 4). (Anissimov & Roberts 1999, 2001, 2004a; Frasch & Barbero 2008; Anissimov & 
Roberts 2009a). 
 
5.4. Random Walk Method 
Diffusion, at its fundamental level, arises from the random thermal motion of molecules 
suspended in a medium. This has led numerous investigators to use a ―random walk‖ simulation 
as a model for diffusion. An unbiased random number generator coupled with local diffusion 
rules, are all that is required computationally. Many diffusion processes, such as molecular 
mobility, phase partitioning and binding, can be simulated by the generation of random integers.  
Frasch applied these processes to simulate diffusion within a complex geometric representation 
of the stratum corneum (Frasch 2002). He correlated diffusivity with the molecular weight of a 
compound, and related corneocyte-lipid partitioning to the octanol-water partition coefficient of 
the compound, so that model results could be regressed to measured permeability coefficients 
(kp) from the Flynn data base (Flynn 1990). He found a correlation coefficient (r
2
) of 0.84, 
compared with 0.67 produced by the Potts and Guy equation.  
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5.5 Estimation of Total Exposure   
 
Up until this section, we have emphasized transport through an isolated skin membrane. In 
practice, however, the transport will need to be evaluated in the context of local or systemic 
action. The solute needs to reach at least the epidermis and potentially dermis to exhibit local or 
systemic toxicity. The generalized equation describing a steady state concentration Css is 
dependent on the steady state flux Jss, the in vivo bioavailability F (for instance accounting for 
loss due to local skin metabolism), the application area A and the clearance CL from either the 
skin (for a local effect) or from the body for a systemic effect (Dancik et al 2008): 
   Css=F.Jss A/CL                                   [41] 
If the target is the epidermis, the epidermal concentrations Css,e is related to the concentration in 
the vehicle Cv by the ratio of the permeability coefficient kp to the dermal clearance CLd (Roberts 
MS 2005): 
   Css,e=kp Cv /(kp+CLd/Ke)     [42] 
Accordingly, if there is no clearance into the dermis due to poor blood flow and/or solubility, Eq. 
42 shows that the epidermal concentration is given by KeCv, where Ke is the epidermis to vehicle 
partition coefficient.  On the other hand, if the dermal clearance is very high, the epidermal 
concentration will be inversely dependent on that clearance, i.e. Css,e~kpKeCv/CLd. The time 
course for establishment of in vivo levels is also more complex than we have described in terms 
of transport across a skin membrane. Here, the time course for elimination from the dermal site 
or from the body as a whole further complicates the kinetic description.  Further, there may be 
solute returning to the site from the blood that can complicate the profiles even further as we 
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have described (Singh P. 1993). For a fuller description of the principles of physiologically-
based drug pharmacokinetics and pharmacodynamics in the skin, the reader is referred to  
(Dancik et al 2008). 
 
 One of the most challenging skin mathematical problems for a biologist is summarizing 
data for finite dose experiments. As a consequence, most biologists rely on using the steady state 
infinite dose solution described earlier in this review.  Unfortunately, it has been shown that the 
penetration profiles for infinite and finite dose formulations can differ quite markedly (for 
example see (Cross et al 2001)).  For a finite volume vehicle application the solute flux can be 
expressed in the Laplace domain [132]   
 
1ˆ
cosh sinhd dN d d
dose
J s
A st V st st


   [43] 
where A is the area of application and donordN
V
V
AhK
  and represents relative volume of the donor 
phase. Whilst experimental data for flux can be fitted by this equation using numerical Laplace 
inversion and regression software, it is not straightforward for many scientists. A simpler 
approach is to use the key features of the flux versus time profile after a finite dose to summarize 
the observed absorption, using model approximations to yield measures for partition and 
diffusion parameters after the finite dose application. For instance, the cumulative amount 
penetrated at any time t is simply the area under the curve of flux versus time to time t as 
determined by the trapezoidal rule or other simple method to estimate area.  The peak flux (Jpeak) 
is the peak in profile of flux versus time (usually a skewed to the left bell shape curve [132] ) and 
time for that peak flux tpeak is most easily defined when the donor volume approaches zero, i.e. 
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0dNV  , as occurs with a solvent deposited solid. The simplified expressions, first described by 
Scheuplein & Ross (Scheuplein & Ross 1974), are:  
 
Jpeak1.850 dose D/(h
2
A)    [44] 
 
tpeak h
2
/(6D)      [45] 
 
where dose/A is dose per unit area (and equals Cv multiplied by thickness of vehicle) [132].  It 
should be noted that Eqs. 44 and 45 are simple solutions for a homogeneous membrane slab and 
do not take into account SC heterogeneity [119] and slow binding within the SC [120] and thus 
might be considered as approximations for certain solutes. 
 
6. SUMMARY AND OUTLOOK 
 
Through the combined efforts of several investigators, mathematical modeling of skin has made 
outstanding progress in the last several decades and various models have been set forth. In 
particular, the QSPRs and other models described here are routinely used to assess, as a first 
pass, the likelihood that a drug can be delivered via the transdermal route. Such predictions 
provide an economic alternative to experimentation. Ultimately, these modeling approaches must 
be combined with a knowledge of the potency of the active at the target site so that 
therapeutically relevant candidates are progressed to final formulations (Cordero et al 2001). 
Real advances in our understanding of percutaneous penetration are best exemplified in those 
cases where models are underpinned by experiment. For example concentration profiles in skin 
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have recently been examined and solutions to Fick‘s second law of diffusion have been used in 
combination with skin stripping to separate the effects of the partition coefficient and the 
diffusion coefficient on permeation (Herkenne et al 2007). With the advent of Confocal Raman 
and other spectroscopic techniques it should now be possible to model and interpret experimental 
concentration profiles of both drug and excipient in vivo. 
 
Mathematical models also provide a means to assess the likelihood of systemic exposure 
upon dermal contact with toxic chemicals. However, the current level of sophistication and 
refinement in the mathematical modeling of chemical transport through skin has not found broad 
application in the areas of dermal exposure and risk assessments. There may be several reasons 
for this. First, many of the models are not easily accessible to the risk assessors and industrial 
hygienists who could use them. Second, many existing predictive models are limited to single 
chemicals in simple matrices such as water, whereas complex mixtures are the rule in most 
industrial and environmental settings. Third, there remains confusion on how to use the results 
from modeling. If a model estimates a permeability coefficient from a given vehicle, how can 
this information be used to predict the mass of chemical that penetrates the skin from a given 
exposure? Finally, there is a valid concern regarding the legitimacy and range of applicability of 
current models. An important challenge for the modeling community is to educate the risk 
assessment community on the appropriate uses and limitations of mathematical models. 
 
 In the United States, documented instances of the application of mathematical modeling 
to dermal risk assessment cite the use of permeability coefficients (kp) and their model-based 
estimation. The US Environmental Protection Agency (EPA) provided guidelines for dermal risk 
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assessment in 1992 (EPA 1992) and advocated the use of the Potts and Guy (Potts & Guy 1992) 
equation for estimating kp where experimental data are unavailable. Subsequent documents (EPA 
2004) incorporate refinements based largely on contributions by Bunge and coworkers (Cleek & 
Bunge 1993; Reddy et al 2000) to estimate dermal absorbed doses from water and soil pathways. 
The Office of Pesticide Programs uses kp for estimating an ―absorbed dose rate‖ from swimming 
in areas treated with pesticides post-application (EPA 1997), and the Office of Solid Waste and 
Emergency Response uses kp to calculate an ―absorbed dose per event‖ for contact with 
chemicals in water at Superfund sites (EPA 2004). In a recent report, these are the only instances 
of the use of an estimate of dermal penetration among 24 reported equations used by the EPA for 
dermal exposure assessment purposes (EPA 2007). The US National Institute for Occupational 
Safety and Health (NIOSH) uses experimental or model-based estimates of kp to calculate 
systemic uptake from skin exposure for comparison with uptake from inhalational exposure at 
the occupational exposure limit of the chemical. The comparison is used for the assignment of 
skin notations, which are hazard warnings used to alert workers and employers to the health risks 
associated with skin exposures to chemicals in the workplace (NIOSH 2009). Sahmel et al. 
(Sahmel 2009) present a number of model-based methods to estimate exposure and absorption of 
substances via the dermal route. The intended audience is industrial hygienists and risk assessors 
tasked with estimating dermal loading on skin, dermal absorption and penetration into the 
systemic circulation. 
 
An important challenge and question from the perspective of the mathematical modeler is 
how much modeling can the data support. For example, if a classic diffusion cell experiment is 
performed, where steady state is established, often the data can only justify fitting a straight line 
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though the steady-state portion of the total amount of solute in the receptor measured as a 
function of time. On the other hand, if different types of experiments are performed and the data 
are analyzed simultaneously as in water penetration and desorption experiments (Anissimov & 
Roberts 2009a) or in the analysis of clobetasol propionate (Mueller et al 2003), one is forced to 
use more advanced modeling. Generally, in an experiment that does not directly measure the 
quantity under the investigation, more complex modeling is required, as in the work on in vivo 
skin penetration (Pirot et al 1997) (Norman et al 2008), where flux was deduced from data 
obtained from measuring concentration of the solute in tape strips and in the breath, respectively.    
 
Another challenge is the large number of parameters that is required for more advanced 
modeling, which is often not readily available. If a simple diffusion model is used, three 
parameters are all that is needed (a partition coefficient, diffusion coefficient and path length). 
When spatial variability of all these parameters in the SC is also modeled, the number of 
parameters becomes staggering, with no realistic experiments to support this kind of modeling.  
Considering slow equilibration in the SC adds two extra parameters (binding and unbinding 
rates). A careful consideration is required, therefore, when adding complexity to modeling for 
the purposes of analyzing data. If donor concentration decreases by less than 20% during the 
experiment, it is most likely that the simplest infinite donor model can be applied, without 
adding an extra parameter for the volume of donor phase (which will be most likely be poorly 
determined from data fitting in this case) and solving the unsteady-state diffusion equation. 
Numerical finite element schemes for solving diffusion equation can easily handle 2D or even 
3D problems given current computing speeds, but whether this voyage to extra dimensions helps 
in modeling skin penetration data has to be carefully considered by the modeler.    
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The ultimate challenge is probably to keep models simple enough, so that it is used by the 
experimental community, while still explaining some complex real world data. Such 
complexities might for example include the changing hydration (and thus diffusion coefficient) 
of the SC in realistic skin penetration scenarios. The co-application of penetration enhancers will 
also produce changing diffusion coefficients and partition coefficients, which at this stage can 
only be modeled by relatively complex models (in the sense of applying it to data) relying on 
finite element or finite difference schemes. Perhaps going back to compartment models, as 
previously suggested (Anissimov 2008), might address the issue of keeping it simple, while 
fitting the real data.  (Vecchia & Bunge 2002a) 
In the long-term, the utility of any mathematical model will be measured against some 
simple requirements: (i) that it offers mechanistic insight consistent with knowledge about skin 
barrier function and percutaneous absorption that has been deduced by validated, independent 
observations;  (ii) that it predicts a parameter suitable for its intended use (e.g., a permeability 
coefficient, or a (trans)dermal flux); (iii) that it is comprehensible to skin scientists with 
―ordinary skill in the art‖, and that the descriptors required by the model are easily calculable or 
readily available in publicly-accessible sources; (iv) that it is broadly applicable across diverse 
chemical classes, not merely specific to one limited group of structurally-related compounds; and 
(v) that modification (which normally means additional complexity) to an existing model 
provides statistically significant results compared to existing methods. 
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